Resources
13 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 10/19/2023 (updated 4/11/2024)
Implementation IV grantees with tools and strategies
Posted 5/26/2021 (updated 4/10/2024)
Posted 3/30/2021 (updated 4/5/2024)
This toolkit provides correctional administrators and health care providers the information necessary to plan and implement MAT programs within jails and prisons.
Posted 3/25/2021 (updated 4/5/2024)
State and Regional Focused Presentations: State Substance Use Prevention Systems and the National Prevention Network
Presenters will review the structure and function of state substance use prevention systems, describe the role and activities of the National Prevention Network, and highlight rural prevention initiatives.
Posted 2/18/2021 (updated 4/4/2024)
Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD.
In this study we sought to assess 3-month outcomes from a patient-centered practice that included MAT with buprenorphine or naltrexone plus the option to participate in psychosocial treatments. The psychosocial treatments included case management, psychotherapy, peer recovery groups such as Narcotics Anonymous or Smart Recovery, or peer support through a local harm reduction program.
Posted 12/16/2020 (updated 4/4/2024)
The curriculum focuses on the effects of substance abuse on families, parenting, and the parent-child relationship, incorporating Joan and Eric Erickson’s eight themes of growth spanning the life cycle and the Stone Center’s Self-in-Relation theory of women’s development. Combining experiential and didactic exercises, this approach is designed to enhance parents’ self-awareness and thereby increase understanding of their children.
Posted 11/17/2021 (updated 4/3/2024)
The National Academies of Science, Engineering, and Medicine defines stigma as a range of negative attitudes, beliefs and behaviors that are associated with certain conditions such as addiction. Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), has been a leading voice in talking about the “chilling effect” stigma has on our ability to address substance use and addiction in our country. In an April 2020 perspective piece published in the New England Journal of Medicine and in her NIDA blog piece, Dr. Volkow explains how stigma can prevent people from seeking care and can even contribute to their continuing addiction. We encourage our visitors to read Dr. Volkow’s writings as well as to familiarize themselves with the efforts to reduce stigma led by the National Institutes of Health (NIH) including the NIH HEAL InitiativeSM, which has made addressing stigma a key element in their efforts to address opioid addiction.
Posted 11/11/2021 (updated 4/3/2024)
In this session, a former RCORP-Planning, current RCORP-Implementation, and newly awarded RCORP-Psychostimulant grantee shared how it used multisectoral collaboration, lived experience, and second-chance employment to build a program from the ground up.
Posted 12/15/2020 (updated 4/3/2024)
The presenters reviewed the structure and function of state substance use prevention systems, described the role and activities of the national prevention network, and highlighted rural prevention initiatives.
Posted 8/4/2021 (updated 4/2/2024)